Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) Consolidated Diluted EPS Stands At $1.0856

0

For the period ended 2015-12-31, Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) delivered annual basic consolidated EPS of $1.1429. In terms of quarterly performance, the basic consolidated EPS was $1.1429 for the quarter ended 2015-12-31.

What about EPS from continuing operations?

Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) produced $1.1429 in basic EPS from continuing operations for the annual period ended 2015-12-31. For the quarter, basic EPS from continuing operations was $1.1429 for the three-month period ended 2015-12-31.

how much did parent contribute in EPS?

Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) received basic EPS boost of $1.1429 from its parent company for the annual period ended 2015-12-31. For quarterly metrics, basic EPS contribution from the parent company was $1.1429 for the three-month period ended 2015-12-31.

Basic net EPS

Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) posted basic net EPS of $1.14 for the annual period ended 2015-12-31. On quarterly basis, the basic net EPS for the quarter ended 2015-12-31 was $1.14.

Consolidated diluted EPS

Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) produced annual consolidated diluted EPS of $1.0856 for the period ended 2015-12-31. But consolidated diluted EPS stood at $1.0856 for the quarter ended 2015-12-31.

Basic diluted EPS

Basic diluted EPS of $1.0856 came from continuing operation for the annual period ended 2015-12-31. In terms of quarterly performance, diluted EPS from continuing operations was $1.0856 for the quarter ended 2015-12-31.

Net diluted EPS

The company posted net diluted EPS of $1.09 for the annual period ended 2015-12-31. Coming to the quarter, it posted net diluted EPS of $1.09 for the three-month period ended 2015-12-31.

Diluted EPS from parent

Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) received diluted EPS boost of $1.0856 from the parent company for the annual period ended 2015-12-31. For the quarter, diluted EPS from the parent was $1.0856 for the quarter ended 2015-12-31.

For the annual period ended 2015-12-31, Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) produced net basic EPS of $1.14. On quarterly basis, it posted basic net EPS of $1.14, which was for the three-month period ended 2015-12-31.

The annual average of the company’s basic shares outstanding was 21.152 for the period ended 2015-12-31. The quarterly average of basic shares outstanding was 21.152 for the quarter ended 2015-12-31.

The company had diluted shares outstanding of 22.267 for the annual period ended 2015-12-31 and 22.267 for the quarterly period ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 9 times, 1 visits today)